nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—Vestibular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0281	0.0281	CcSEcCtD
Gabapentin—Function kidney decreased—Cyclosporine—focal segmental glomerulosclerosis	0.0258	0.0258	CcSEcCtD
Gabapentin—Tendon disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0216	0.0216	CcSEcCtD
Gabapentin—Salivary gland enlargement—Cyclosporine—focal segmental glomerulosclerosis	0.0203	0.0203	CcSEcCtD
Gabapentin—Skin cancer—Cyclosporine—focal segmental glomerulosclerosis	0.0182	0.0182	CcSEcCtD
Gabapentin—Non-Hodgkin's lymphoma—Cyclosporine—focal segmental glomerulosclerosis	0.0161	0.0161	CcSEcCtD
Gabapentin—Lymphoma—Cyclosporine—focal segmental glomerulosclerosis	0.0161	0.0161	CcSEcCtD
Gabapentin—Goitre—Cyclosporine—focal segmental glomerulosclerosis	0.0158	0.0158	CcSEcCtD
Gabapentin—Paresis—Cyclosporine—focal segmental glomerulosclerosis	0.0154	0.0154	CcSEcCtD
Gabapentin—Pyelonephritis—Cyclosporine—focal segmental glomerulosclerosis	0.0148	0.0148	CcSEcCtD
Gabapentin—Conjunctival hyperaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0128	0.0128	CcSEcCtD
Gabapentin—Leukorrhea—Cyclosporine—focal segmental glomerulosclerosis	0.012	0.012	CcSEcCtD
Gabapentin—Trauma—Cyclosporine—focal segmental glomerulosclerosis	0.0118	0.0118	CcSEcCtD
Gabapentin—Nephropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0118	0.0118	CcSEcCtD
Gabapentin—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.0117	0.0117	CcSEcCtD
Gabapentin—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.0102	0.0102	CcSEcCtD
Gabapentin—Micturition urgency—Cyclosporine—focal segmental glomerulosclerosis	0.00992	0.00992	CcSEcCtD
Gabapentin—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.00992	0.00992	CcSEcCtD
Gabapentin—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.00969	0.00969	CcSEcCtD
Gabapentin—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.00969	0.00969	CcSEcCtD
Gabapentin—Hirsutism—Cyclosporine—focal segmental glomerulosclerosis	0.00969	0.00969	CcSEcCtD
Gabapentin—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00958	0.00958	CcSEcCtD
Gabapentin—Vaginal discharge—Cyclosporine—focal segmental glomerulosclerosis	0.00926	0.00926	CcSEcCtD
Gabapentin—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.00926	0.00926	CcSEcCtD
Gabapentin—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.00896	0.00896	CcSEcCtD
Gabapentin—Encephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00877	0.00877	CcSEcCtD
Gabapentin—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00868	0.00868	CcSEcCtD
Gabapentin—Tooth disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00868	0.00868	CcSEcCtD
Gabapentin—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00842	0.00842	CcSEcCtD
Gabapentin—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00826	0.00826	CcSEcCtD
Gabapentin—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00781	0.00781	CcSEcCtD
Gabapentin—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00774	0.00774	CcSEcCtD
Gabapentin—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00748	0.00748	CcSEcCtD
Gabapentin—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00723	0.00723	CcSEcCtD
Gabapentin—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00723	0.00723	CcSEcCtD
Gabapentin—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00718	0.00718	CcSEcCtD
Gabapentin—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00718	0.00718	CcSEcCtD
Gabapentin—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.00712	0.00712	CcSEcCtD
Gabapentin—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.00669	0.00669	CcSEcCtD
Gabapentin—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00645	0.00645	CcSEcCtD
Gabapentin—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00641	0.00641	CcSEcCtD
Gabapentin—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00641	0.00641	CcSEcCtD
Gabapentin—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00636	0.00636	CcSEcCtD
Gabapentin—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00624	0.00624	CcSEcCtD
Gabapentin—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00624	0.00624	CcSEcCtD
Gabapentin—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00619	0.00619	CcSEcCtD
Gabapentin—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00619	0.00619	CcSEcCtD
Gabapentin—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00619	0.00619	CcSEcCtD
Gabapentin—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.00611	0.00611	CcSEcCtD
Gabapentin—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00611	0.00611	CcSEcCtD
Gabapentin—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00611	0.00611	CcSEcCtD
Gabapentin—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00607	0.00607	CcSEcCtD
Gabapentin—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00603	0.00603	CcSEcCtD
Gabapentin—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00592	0.00592	CcSEcCtD
Gabapentin—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00592	0.00592	CcSEcCtD
Gabapentin—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00592	0.00592	CcSEcCtD
Gabapentin—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00563	0.00563	CcSEcCtD
Gabapentin—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00553	0.00553	CcSEcCtD
Gabapentin—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00544	0.00544	CcSEcCtD
Gabapentin—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00538	0.00538	CcSEcCtD
Gabapentin—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00535	0.00535	CcSEcCtD
Gabapentin—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00529	0.00529	CcSEcCtD
Gabapentin—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00517	0.00517	CcSEcCtD
Gabapentin—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00515	0.00515	CcSEcCtD
Gabapentin—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00509	0.00509	CcSEcCtD
Gabapentin—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00504	0.00504	CcSEcCtD
Gabapentin—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00491	0.00491	CcSEcCtD
Gabapentin—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00489	0.00489	CcSEcCtD
Gabapentin—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00489	0.00489	CcSEcCtD
Gabapentin—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00479	0.00479	CcSEcCtD
Gabapentin—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.0047	0.0047	CcSEcCtD
Gabapentin—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00468	0.00468	CcSEcCtD
Gabapentin—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00466	0.00466	CcSEcCtD
Gabapentin—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00461	0.00461	CcSEcCtD
Gabapentin—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00457	0.00457	CcSEcCtD
Gabapentin—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00457	0.00457	CcSEcCtD
Gabapentin—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00457	0.00457	CcSEcCtD
Gabapentin—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00455	0.00455	CcSEcCtD
Gabapentin—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00455	0.00455	CcSEcCtD
Gabapentin—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00453	0.00453	CcSEcCtD
Gabapentin—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00445	0.00445	CcSEcCtD
Gabapentin—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00441	0.00441	CcSEcCtD
Gabapentin—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00435	0.00435	CcSEcCtD
Gabapentin—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0043	0.0043	CcSEcCtD
Gabapentin—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00428	0.00428	CcSEcCtD
Gabapentin—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00424	0.00424	CcSEcCtD
Gabapentin—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00421	0.00421	CcSEcCtD
Gabapentin—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00419	0.00419	CcSEcCtD
Gabapentin—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00419	0.00419	CcSEcCtD
Gabapentin—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00417	0.00417	CcSEcCtD
Gabapentin—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00409	0.00409	CcSEcCtD
Gabapentin—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00406	0.00406	CcSEcCtD
Gabapentin—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00402	0.00402	CcSEcCtD
Gabapentin—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00402	0.00402	CcSEcCtD
Gabapentin—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00387	0.00387	CcSEcCtD
Gabapentin—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00383	0.00383	CcSEcCtD
Gabapentin—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00375	0.00375	CcSEcCtD
Gabapentin—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00369	0.00369	CcSEcCtD
Gabapentin—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00362	0.00362	CcSEcCtD
Gabapentin—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.00361	CcSEcCtD
Gabapentin—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00353	0.00353	CcSEcCtD
Gabapentin—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00348	0.00348	CcSEcCtD
Gabapentin—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00346	0.00346	CcSEcCtD
Gabapentin—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00344	0.00344	CcSEcCtD
Gabapentin—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.0034	0.0034	CcSEcCtD
Gabapentin—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.0033	0.0033	CcSEcCtD
Gabapentin—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00328	0.00328	CcSEcCtD
Gabapentin—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00326	0.00326	CcSEcCtD
Gabapentin—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00322	0.00322	CcSEcCtD
Gabapentin—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.0032	0.0032	CcSEcCtD
Gabapentin—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00319	0.00319	CcSEcCtD
Gabapentin—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00317	0.00317	CcSEcCtD
Gabapentin—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00315	0.00315	CcSEcCtD
Gabapentin—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00315	0.00315	CcSEcCtD
Gabapentin—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00314	0.00314	CcSEcCtD
Gabapentin—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00311	0.00311	CcSEcCtD
Gabapentin—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.0031	0.0031	CcSEcCtD
Gabapentin—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00309	0.00309	CcSEcCtD
Gabapentin—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00309	0.00309	CcSEcCtD
Gabapentin—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00307	0.00307	CcSEcCtD
Gabapentin—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00307	0.00307	CcSEcCtD
Gabapentin—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00306	0.00306	CcSEcCtD
Gabapentin—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00306	0.00306	CcSEcCtD
Gabapentin—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.003	0.003	CcSEcCtD
Gabapentin—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00298	0.00298	CcSEcCtD
Gabapentin—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00297	0.00297	CcSEcCtD
Gabapentin—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00296	0.00296	CcSEcCtD
Gabapentin—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.00284	CcSEcCtD
Gabapentin—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00283	0.00283	CcSEcCtD
Gabapentin—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00283	0.00283	CcSEcCtD
Gabapentin—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.00281	CcSEcCtD
Gabapentin—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.00281	CcSEcCtD
Gabapentin—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00279	0.00279	CcSEcCtD
Gabapentin—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00278	0.00278	CcSEcCtD
Gabapentin—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00277	0.00277	CcSEcCtD
Gabapentin—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00273	0.00273	CcSEcCtD
Gabapentin—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00264	0.00264	CcSEcCtD
Gabapentin—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00255	0.00255	CcSEcCtD
Gabapentin—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.00254	CcSEcCtD
Gabapentin—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.0025	0.0025	CcSEcCtD
Gabapentin—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00248	0.00248	CcSEcCtD
Gabapentin—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00246	0.00246	CcSEcCtD
Gabapentin—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00243	0.00243	CcSEcCtD
Gabapentin—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00242	0.00242	CcSEcCtD
Gabapentin—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00241	0.00241	CcSEcCtD
Gabapentin—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00239	0.00239	CcSEcCtD
Gabapentin—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00237	0.00237	CcSEcCtD
Gabapentin—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00232	0.00232	CcSEcCtD
Gabapentin—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00231	0.00231	CcSEcCtD
Gabapentin—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00228	0.00228	CcSEcCtD
Gabapentin—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00228	0.00228	CcSEcCtD
Gabapentin—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00226	0.00226	CcSEcCtD
Gabapentin—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00225	CcSEcCtD
Gabapentin—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.00222	CcSEcCtD
Gabapentin—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.00221	CcSEcCtD
Gabapentin—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.0022	0.0022	CcSEcCtD
Gabapentin—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00215	0.00215	CcSEcCtD
Gabapentin—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00213	0.00213	CcSEcCtD
Gabapentin—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00213	0.00213	CcSEcCtD
Gabapentin—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.0021	CcSEcCtD
Gabapentin—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.0021	CcSEcCtD
Gabapentin—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.0021	CcSEcCtD
Gabapentin—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00209	0.00209	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00208	0.00208	CcSEcCtD
Gabapentin—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00207	CcSEcCtD
Gabapentin—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.00205	CcSEcCtD
Gabapentin—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.00203	CcSEcCtD
Gabapentin—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.00201	CcSEcCtD
Gabapentin—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.00201	CcSEcCtD
Gabapentin—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.002	CcSEcCtD
Gabapentin—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00197	CcSEcCtD
Gabapentin—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00197	CcSEcCtD
Gabapentin—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00195	CcSEcCtD
Gabapentin—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00194	CcSEcCtD
Gabapentin—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.00192	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00183	CcSEcCtD
Gabapentin—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.00182	CcSEcCtD
Gabapentin—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.0018	CcSEcCtD
Gabapentin—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00179	0.00179	CcSEcCtD
Gabapentin—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00179	0.00179	CcSEcCtD
Gabapentin—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00177	CcSEcCtD
Gabapentin—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00175	0.00175	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.00173	CcSEcCtD
Gabapentin—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.00173	CcSEcCtD
Gabapentin—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00172	CcSEcCtD
Gabapentin—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00172	CcSEcCtD
Gabapentin—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.00166	CcSEcCtD
Gabapentin—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00164	CcSEcCtD
Gabapentin—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.0016	CcSEcCtD
Gabapentin—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00159	CcSEcCtD
Gabapentin—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00159	CcSEcCtD
Gabapentin—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00148	CcSEcCtD
Gabapentin—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00144	CcSEcCtD
Gabapentin—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00142	CcSEcCtD
Gabapentin—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00137	CcSEcCtD
Gabapentin—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00133	CcSEcCtD
Gabapentin—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00128	CcSEcCtD
Gabapentin—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00127	CcSEcCtD
Gabapentin—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00127	CcSEcCtD
Gabapentin—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00126	CcSEcCtD
Gabapentin—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00119	CcSEcCtD
